AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Short Interest Rises 112.5%

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 79,632 shares, a growth of 112.5% from the September 30th total of 37,469 shares. Currently, 3.7% of the shares of the stock are sold short. Based on an average trading volume of 22,486 shares, the short-interest ratio is presently 3.5 days.

AdvisorShares Psychedelics ETF Price Performance

Shares of AdvisorShares Psychedelics ETF stock traded down $0.60 during trading on Friday, hitting $21.00. 11,971 shares of the company’s stock traded hands, compared to its average volume of 32,718. The firm’s fifty day moving average price is $23.09 and its 200 day moving average price is $20.71. AdvisorShares Psychedelics ETF has a twelve month low of $15.63 and a twelve month high of $27.02.

Institutional Investors Weigh In On AdvisorShares Psychedelics ETF

A hedge fund recently bought a new position in AdvisorShares Psychedelics ETF stock. Vigilare Wealth Management bought a new position in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 8,800 shares of the company’s stock, valued at approximately $212,000. Vigilare Wealth Management owned 0.47% of AdvisorShares Psychedelics ETF at the end of the most recent reporting period.

AdvisorShares Psychedelics ETF Company Profile

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.